CASP3 and meningioma: Our findings showing increased serum levels of caspase-3 are supported by an earlier study reporting an increased caspase-3 immunoreactivity in meningioma tissues, in which Grade II and Grade III meningioma tissues exhibited higher scores of immunopositivity relative to the benign Grade I meningioma tissues (34).